Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Closure

IND.172 -- A phase II study of bortezomib and gemcitabine in patients with relapsed mantle cell lymphoma -- was closed to accrual on September 19, 2008.
http://www.ctg.queensu.ca/trials/ind/i172/172.html